Woman stirring a drink beside MIP Vitality Blend and breakfast on a balcony table

The Gut-Immune Connection: Why Digestive Balance Matters

Learn how the gut environment, intestinal lining and local immune activity communicate as part of everyday wellbeing.

The digestive tract is one of the body’s busiest meeting points with the outside world. Food, microorganisms and countless naturally occurring compounds pass through it every day. The intestinal lining must allow useful nutrients and water to cross while local immune systems monitor what is present and respond appropriately.

This relationship is often called the gut–immune connection. It involves the intestinal lining, mucus, immune cells, signalling molecules and the community of microorganisms living in the digestive tract. Bovine colostrum contains naturally occurring components that have been studied in relation to both gastrointestinal and immune outcomes, but the precise links remain complex and should not be reduced to a promise that one supplement will “fix” the gut or “boost” immunity.

  • The intestinal lining, gut microorganisms and local immune cells communicate continuously to maintain a balanced response.
  • A healthy immune response is regulated and appropriate not simply stronger or more active.
  • Bovine-colostrum research is encouraging in selected populations, but it does not prove that MIP changes the microbiome or produces every outcome reported with another product.

The intestine has an unusually large surface area and is continually exposed to food components, resident microorganisms and material that may be unfamiliar to the body. It therefore contains extensive networks of innate and adaptive immune cells within and beneath the intestinal lining.

These cells do more than react to threats. They also help maintain tolerance to ordinary foods and beneficial or harmless microorganisms. The objective is a measured response: active when needed, restrained when a reaction would be unnecessary.

The intestinal lining contributes to this regulation by acting as both a physical boundary and an active signalling surface. Mucus, epithelial cells and immune cells work together rather than functioning as separate systems.

The gut microbiome is the collection of microorganisms and their genetic material within the digestive tract. These organisms interact with food, produce metabolites and exchange signals with intestinal and immune cells. Their composition varies considerably between individuals and can change over time.

A diverse diet containing a range of plant foods can help provide substrates used by many gut microorganisms. Sleep, physical activity, medication use, illness and other individual factors may also influence the gut environment.

Microbiome science is developing rapidly, but broad marketing phrases such as “balances the microbiome” are difficult to substantiate without direct testing.

Microorganisms and food-derived compounds can influence epithelial and immune signalling within the gut. In turn, immune activity helps shape the local environment by supporting barrier function and responding to material recognised as potentially harmful.

This communication involves many pathways. Innate immune cells can respond quickly to microbial signals, while adaptive immune cells develop more targeted responses. Other immune cells help regulate tolerance and tissue maintenance. The result is not a simple on/off switch but a constantly adjusted network.

Because the network is so interconnected, digestive and immune wellbeing can overlap. That does not mean every immune symptom begins in the gut or that changing the diet or taking a supplement will resolve a diagnosed immune condition.

MIP Colostrum naturally contains immunoglobulins, lactoferrin, peptides and growth-related factors. When taken orally, research interest centres largely on their possible interactions within the gastrointestinal tract rather than the idea that bovine antibodies enter the bloodstream and become human antibodies.

Reviews of orally consumed bovine immunoglobulins report that some intact or partly intact material can survive digestion, although the proportion varies. This provides a possible basis for local interaction in the gut, but it does not prove a specific everyday health result.

MIP Colostrum should therefore be positioned as a complex food supplement containing naturally occurring components studied in relation to mucosal, gastrointestinal and immune outcomes not as an immune medicine or a replacement for a varied diet, sleep, vaccination or medical care.

Much of the human research linking bovine colostrum with immune outcomes has involved athletes or other physically active adults. A 2016 systematic review and meta-analysis identified five randomized trials involving 152 exercise-trained adults. The pooled analysis found fewer days and episodes with self-reported upper-respiratory symptoms, but the authors emphasised the small evidence base, incomplete reporting and moderate or high risk of bias in most included studies.

A 2014 randomized trial used 20 g/day for 12 weeks in 53 active men and reported fewer upper-respiratory symptom days and episodes than placebo. However, several measured immune markers did not change, so the biological mechanism remained unclear. These outcomes relate to a specific product, dose and population rather than proving a general gut-mediated immune effect.

A more recent trial in university students used 0.5–1 g/day and reported fewer and less severe self-reported upper-respiratory symptoms in a defined subgroup. The study is interesting because the dose was lower, but it relied on participant questionnaires. Taken together, the studies support continued research, not a universal promise.

Bovine-colostrum immune studies have used widely different quantities, including 20 g/day in some athlete trials and 0.5–1 g/day in the university-student trial. Products also differ in collection timing, composition, processing and biological activity. The number of grams cannot be interpreted in isolation.

MIP’s standard adult serving is 2 g daily. With batch-verified IgG of 20–25%, this provides approximately 400–500 mg of IgG per serving. MIP Colostrum is produced from fresh, never-frozen New Zealand colostrum collected from the first two milkings.

These specifications allow MIP to describe its own product accurately. They do not establish that MIP will reproduce outcomes reported with another colostrum product, dose or study population.

Everyday digestive and immune wellbeing rests on more than one food or supplement. A varied diet, adequate sleep, regular appropriate activity, hydration, stress management and recommended healthcare all play important roles.

Adults who choose MIP Colostrum can incorporate the standard 2 g daily serving into a consistent nutrition routine.

MIP Colostrum is a food supplement. People with milk allergy, pregnancy, medication use, diagnosed gastrointestinal or immune conditions, or persistent or concerning symptoms should obtain appropriate professional advice.

Choose MIP Colostrum in the format that suits you

Complement your daily routine with Omega-3 Krill Oil.

Continue exploring

Related reading

Have a question about MIP Colostrum?

Visit our Frequently Asked Questions or contact the MIP team.

References

  1. Yao Y, et al. Epithelial–immune cell crosstalk for intestinal barrier homeostasis. European Journal of Immunology. 2024. PMID: 38556632.
  2. Jasion VS, Burnett BP. Survival and digestibility of orally administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans. Nutrition Journal. 2015;14:22. PMID: 25880525.
  3. Jones AW, et al. Bovine colostrum supplementation and upper respiratory illness in active males: a systematic review and meta-analysis. BMC Sports Science, Medicine and Rehabilitation. 2016;8:21. PMID: 27462401.
  4. Jones AW, et al. Effects of bovine colostrum supplementation on in vivo immunity and upper respiratory illness in active males. Brain, Behavior, and Immunity. 2014;39:194–203. doi:10.1016/j.bbi.2013.10.032.
  5. Baśkiewicz-Hałasa M, et al. Moderate dose bovine colostrum supplementation in prevention of upper respiratory tract infections in medical university students: a randomized, triple blind, placebo-controlled trial. Nutrients. 2023;15(8):1925. PMID: 37111143.
  6. Davison G. The use of bovine colostrum in sport and exercise. Nutrients. 2021;13(6):1789. PMID: 34073917. Note: the author reported previous research funding and honoraria from colostrum suppliers.

This article provides general nutritional information and is not intended to diagnose, treat, cure or prevent any disease. Individual needs vary. Follow the product label and seek advice from a qualified health professional where appropriate.